Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) — Baton Rouge, Louisiana

Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) is a clinical research site located in Baton Rouge, Louisiana, United States 70817.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Baton Rouge

Browse all research sites in Louisiana · View every site in Baton Rouge

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042)?

Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) conducted?

Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms.

Is Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) accredited by Crixeo Clinical Trials?

Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.